Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China
· Delayed Price · Currency is CNY
73.17
-0.76 (-1.03%)
Nov 22, 2024, 3:00 PM CST
Beijing Wantai Biological Pharmacy Enterprise Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 2,533 | 3,819 | 5,193 | 1,416 | 710.67 | 283.99 | Upgrade
|
Short-Term Investments | 650 | 400 | - | 200 | 52.54 | 5 | Upgrade
|
Trading Asset Securities | 2,317 | 2,055 | 2,009 | 40.39 | 50.36 | 58 | Upgrade
|
Cash & Short-Term Investments | 5,500 | 6,274 | 7,201 | 1,656 | 813.57 | 346.99 | Upgrade
|
Cash Growth | -3.78% | -12.88% | 334.83% | 103.56% | 134.46% | -18.81% | Upgrade
|
Accounts Receivable | 2,465 | 2,999 | 3,960 | 2,277 | 711.6 | 261.39 | Upgrade
|
Other Receivables | 27.17 | 48.71 | 5.15 | 12.45 | 13.04 | 0.5 | Upgrade
|
Receivables | 2,492 | 3,053 | 3,970 | 2,292 | 724.64 | 264.02 | Upgrade
|
Inventory | 846.24 | 905.48 | 869.14 | 593.17 | 400.04 | 236.43 | Upgrade
|
Prepaid Expenses | - | - | - | - | - | 0.16 | Upgrade
|
Other Current Assets | 148.95 | 69.42 | 139.4 | 105.2 | 39.54 | 38.05 | Upgrade
|
Total Current Assets | 8,988 | 10,302 | 12,180 | 4,647 | 1,978 | 885.66 | Upgrade
|
Property, Plant & Equipment | 3,255 | 2,641 | 2,235 | 1,703 | 790.98 | 627.7 | Upgrade
|
Long-Term Investments | 1,131 | 1,432 | 911.3 | 61.3 | 211.3 | 228.5 | Upgrade
|
Other Intangible Assets | 517.11 | 507.24 | 289.37 | 289.92 | 226.66 | 232.67 | Upgrade
|
Long-Term Deferred Tax Assets | 159.32 | 157.95 | 66.01 | 68.97 | 56.49 | 93.69 | Upgrade
|
Long-Term Deferred Charges | 240.41 | 215.33 | 175.49 | 27.18 | 27.76 | 27.05 | Upgrade
|
Other Long-Term Assets | 449.75 | 459.41 | 372.3 | 249.09 | 212.7 | 69.65 | Upgrade
|
Total Assets | 14,739 | 15,715 | 16,230 | 7,046 | 3,504 | 2,165 | Upgrade
|
Accounts Payable | 430.38 | 234.28 | 275.47 | 154.08 | 107.29 | 85.05 | Upgrade
|
Accrued Expenses | 156.61 | 1,653 | 2,572 | 1,541 | 440.8 | 147.66 | Upgrade
|
Short-Term Debt | 97.64 | 81.14 | 140.14 | 235.64 | 77.66 | - | Upgrade
|
Current Portion of Long-Term Debt | 33.14 | 87.19 | 3.07 | - | - | - | Upgrade
|
Current Portion of Leases | - | 13.3 | 13.73 | 13.93 | - | - | Upgrade
|
Current Income Taxes Payable | 21.95 | 7.49 | 99.02 | 146.55 | 4.37 | 7.84 | Upgrade
|
Current Unearned Revenue | 39.83 | 70.38 | 82.28 | 70.3 | 40.92 | - | Upgrade
|
Other Current Liabilities | 1,170 | 523.42 | 299.34 | 204.64 | 157.98 | 251.48 | Upgrade
|
Total Current Liabilities | 1,949 | 2,670 | 3,485 | 2,366 | 829.03 | 492.03 | Upgrade
|
Long-Term Debt | 136.25 | 115.36 | 102.49 | 4.9 | - | 21 | Upgrade
|
Long-Term Leases | 11.38 | 12.36 | 18.43 | 32.59 | - | - | Upgrade
|
Long-Term Unearned Revenue | 33.29 | 33.65 | 41.37 | 76.44 | 94.26 | 71.16 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 17.15 | - | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | - | 3.8 | - | - | Upgrade
|
Total Liabilities | 2,130 | 2,831 | 3,665 | 2,483 | 923.29 | 584.19 | Upgrade
|
Common Stock | 1,265 | 1,268 | 906.07 | 607.04 | 433.6 | 390 | Upgrade
|
Additional Paid-In Capital | 3,139 | 3,312 | 3,729 | 445.83 | 446.27 | 172.02 | Upgrade
|
Retained Earnings | 8,111 | 8,250 | 7,906 | 3,413 | 1,674 | 996.8 | Upgrade
|
Treasury Stock | -92.17 | -129.42 | -200.17 | - | - | - | Upgrade
|
Total Common Equity | 12,423 | 12,701 | 12,341 | 4,466 | 2,554 | 1,559 | Upgrade
|
Minority Interest | 186.14 | 183.06 | 223.63 | 96.2 | 26.73 | 21.91 | Upgrade
|
Shareholders' Equity | 12,609 | 12,884 | 12,565 | 4,562 | 2,580 | 1,581 | Upgrade
|
Total Liabilities & Equity | 14,739 | 15,715 | 16,230 | 7,046 | 3,504 | 2,165 | Upgrade
|
Total Debt | 278.41 | 309.35 | 277.86 | 287.06 | 77.66 | 21 | Upgrade
|
Net Cash (Debt) | 5,222 | 5,965 | 6,923 | 1,369 | 735.91 | 325.99 | Upgrade
|
Net Cash Growth | -4.01% | -13.85% | 405.71% | 86.03% | 125.74% | -19.78% | Upgrade
|
Net Cash Per Share | 4.13 | 4.73 | 5.54 | 1.11 | 0.62 | 0.30 | Upgrade
|
Filing Date Shares Outstanding | 1,329 | 1,268 | 1,268 | 1,232 | 1,232 | 1,108 | Upgrade
|
Total Common Shares Outstanding | 1,329 | 1,268 | 1,268 | 1,232 | 1,232 | 1,108 | Upgrade
|
Working Capital | 7,038 | 7,632 | 8,695 | 2,281 | 1,149 | 393.63 | Upgrade
|
Book Value Per Share | 9.35 | 10.01 | 9.73 | 3.62 | 2.07 | 1.41 | Upgrade
|
Tangible Book Value | 11,906 | 12,193 | 12,052 | 4,176 | 2,327 | 1,326 | Upgrade
|
Tangible Book Value Per Share | 8.96 | 9.61 | 9.50 | 3.39 | 1.89 | 1.20 | Upgrade
|
Buildings | - | 724.87 | 628.89 | 392.67 | 253.3 | 246.27 | Upgrade
|
Machinery | - | 1,510 | 1,185 | 666.87 | 565.97 | 490.03 | Upgrade
|
Construction In Progress | - | 814.56 | 720.51 | 924.38 | 231.5 | 81.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.